(Fixed combination and adherence in patients with recent myocardial infarction or manifest cardiovascular disease - our experience from the SECURE trial)

Jean-Claude Lubanda, Hana Lubanda

Cor Vasa 2024, 66(2):99-102 | DOI: 10.33678/cor.2024.022  

A lack of adherence is associated with a worse prognosis. Decreasing adherence in post-MI patients leads to an increased risk of recurrence of ischemic events. In addition, due to the aging population and improved quality care for ACS with better survival, there is an increase in the number of patients who need more personalized secondary preventive interventions. For these patients, improving adherence is another way to improve their prognosis. The latest research shows that combination therapy, preferably in a fixed combination, should improve patient adherence and reduce the risk of CV disease complications. Thanks to the reduction in the number...

(Focused on heart failure treatment according to the updated 2023 guidelines)

Jaroslav Brotánek

Cor Vasa 2024, 66(2):105-111 | DOI: 10.33678/cor.2024.025  

Acute and chronic heart failure remains a very serious and high priority problem in contemporary cardiology. New, modern drugs are currently emerging in the treatment of heart failure while the possibilities of their further use for this diagnosis are being expanded. These findings have been summarized in the 2023 update of the European Society of Cardiology Guidelines for heart failure. This article provides a brief summary of the new developments in pharmacotherapy based on the above recommendations.

Doporučený postup Evropské kardiologické společnosti pro léčbu endokarditidy 2023.

Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, Caselli S, Doenst T, Ederhy S, Erba PA, Foldager D, Fosbøl EL, Kovac J, Mestres CA, Miller OI, Miro JM, Pazdernik M, Pizzi MN, Quintana E, Rasmussen TB, Ristić AD, Rodés-Cabau J, Sionis A, Zühlke LJ, Borger MA, Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, Caselli S, Doenst T, Ederhy S, Erba PA, Foldager D, Fosbøl EL, Kovac J, Mestres CA, Miller OI, Miro JM, Pazdernik M, Pizzi MN, Quintana E, Rasmussen TB, Ristić AD, Rodés-Cabau J, Sionis A, Zühlke LJ, Borger MA, Hana Línková, Dan Marek, Martin Mates, Jiří Beneš, Aleš Mokráček, Jana Rubáčková Popelová, Jan Janoušek, Tomáš Paleček, Michal Pazderník, Tomáš Zatočil

Cor Vasa 2024, 66(2):112-168 | DOI: 10.33678/cor.2024.017  

Doporučení ESC pro léčbu akutních koronárních syndromů 2023.

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Petr Kala, Petr Ošťádal, Zuzana Moťovská, Martin Mates, Dagmar Vondráková, Jan Bělohlávek, Petr Fila, Ivo Varvařovský

Cor Vasa 2024, 66(2):169-232 | DOI: 10.33678/cor.2024.029  

Doporučený postup Evropské kardiologické společnosti pro léčbu kardiovaskulárních onemocnění u pacientů s diabetem 2023.

Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, Christodorescu RM, Crawford C, Di Angelantonio E, Eliasson B, Espinola-Klein C, Fauchier L, Halle M, Herrington WG, Kautzky-Willer A, Lambrinou E, Lesiak M, Lettino M, McGuire DK, Mullens W, Rocca B, Sattar N, Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, Christodorescu RM, Crawford C, Di Angelantonio E, Eliasson B, Espinola-Klein C, Fauchier L, Halle M, Herrington WG, Kautzky-Willer A, Lambrinou E, Lesiak M, Lettino M, McGuire DK, Mullens W, Rocca B, Sattar N, Michal Vrablík, Hana Rosolová, Miloš Táborský

Cor Vasa 2024, 66(2):233-279 | DOI: 10.33678/cor.2024.031  

Aktualizace Doporučení ESC pro diagnostiku a léčbu akutního a chronického srdečního selhání 2021. Vypracovaná Pracovní skupinou pro diagnostiku a léčbu akutního a chronického srdečního selhání Evropské kardiologické společnosti (ESC). Se zvláštním přispěním Evropské asociace srdečního selhání ESC.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, Jan Krejčí, Lenka Špinarová, Jiří Pařenica, Anna Chaloupka, Jiří Veselý

Cor Vasa 2024, 66(2):280-288 | DOI: 10.33678/cor.2024.018  

Jiří Bonaventura: Současná kardiologie. Manuál pro praxi

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2024, 66(2):296  

Prof. MUDr. Petr Widimský, DrSc., FESC, FACC, sedmdesátiletý

Pavel Gregor

Cor Vasa 2024, 66(2):291-293  

Profesor Petr Widimský slaví životní jubileum

Michael Aschermann

Cor Vasa 2024, 66(2):294  

Profesor MUDr. Aleš Linhart, DrSc., FESC, FCMA, slaví životní jubileum

Michael Aschermann

Cor Vasa 2024, 66(2):295